143

Neurology
Focuses on brain health.
Sub Categories on Neurology
Latest Articles
Reelin reverts the main pathological processes related to Alzheimer's and other tauopathy

Reelin reverts the main pathological processes related to Alzheimer's and other tauopathy

by University of BarcelonaImage of a primary neuronal cell culture with detection of MAP2 dendritic marker (red) and Neurofilament axon marker (green). Credit: University of BarcelonaPromoting th

Reelin reverts the main pathological processes related to Alzheimer's and other tauopathy

by University of BarcelonaImage of a primary neuronal cell culture with detection of MAP2 dendritic marker (red) and Neurofilament axon marker (green). Credit: University of BarcelonaPromoting th
Researchers identify new mutation in gene linked to amyotrophic lateral sclerosis

Researchers identify new mutation in gene linked to amyotrophic lateral sclerosis

by Institut de Recerca Sant Pau (Sant Pau Research Institute)(A) Map of Spain and its regions. (B) Map of La Rioja province and its regions. Regions belonging to the south-eastern area of La Rioja, wh

Researchers identify new mutation in gene linked to amyotrophic lateral sclerosis

by Institut de Recerca Sant Pau (Sant Pau Research Institute)(A) Map of Spain and its regions. (B) Map of La Rioja province and its regions. Regions belonging to the south-eastern area of La Rioja, wh
Precise map of primate foveolar cortex uncovers intricacies of brain's visual system

Precise map of primate foveolar cortex uncovers intricacies of brain's visual system

by Ingrid Fadelli , Medical XpressColor-coded responses to different visual stimuli. a, Activations to achromatic high-SF gratings (in cycles per degree). Yellow, SF11; purple, SF15; orange, SF18. b,

Precise map of primate foveolar cortex uncovers intricacies of brain's visual system

by Ingrid Fadelli , Medical XpressColor-coded responses to different visual stimuli. a, Activations to achromatic high-SF gratings (in cycles per degree). Yellow, SF11; purple, SF15; orange, SF18. b,
Early abnormalities of Alzheimer's disease: It takes two (proteins) to tango

Early abnormalities of Alzheimer's disease: It takes two (proteins) to tango

by McGill UniversityCredit: McGill UniversityFor years, neuroscientists have puzzled over how two abnormal proteins, called amyloid and tau, accumulate in the brain and damage it to cause Alzheim

Early abnormalities of Alzheimer's disease: It takes two (proteins) to tango

by McGill UniversityCredit: McGill UniversityFor years, neuroscientists have puzzled over how two abnormal proteins, called amyloid and tau, accumulate in the brain and damage it to cause Alzheim
Pimavanserin reduced symptoms of dementia-related psychosis in phase 3 trial

Pimavanserin reduced symptoms of dementia-related psychosis in phase 3 trial

by University of ExeterA large-scale trial has found a treatment with pimavanserin substantially reduced psychotic symptoms and reduced risk of relapse of those symptoms compared to placebo in pe

Pimavanserin reduced symptoms of dementia-related psychosis in phase 3 trial

by University of ExeterA large-scale trial has found a treatment with pimavanserin substantially reduced psychotic symptoms and reduced risk of relapse of those symptoms compared to placebo in pe
Alzheimer's disease: Five things to know

Alzheimer's disease: Five things to know

Credit: Unsplash/CC0 Public DomainAlzheimer's disease, a devastating neuro-degenerative condition that causes dementia, affects more than 30 million people worldwide and remains an illness for whi

Alzheimer's disease: Five things to know

Credit: Unsplash/CC0 Public DomainAlzheimer's disease, a devastating neuro-degenerative condition that causes dementia, affects more than 30 million people worldwide and remains an illness for whi
Alzheimer's drug gantenerumab fails to slow decline in phase III clinical trial

Alzheimer's drug gantenerumab fails to slow decline in phase III clinical trial

by Alzheimer's Research UKCredit: Pixabay/CC0 Public DomainThe pharmaceutical company Roche has announced that two phase III trials of the potential Alzheimer's drug gantenerumab did not

Alzheimer's drug gantenerumab fails to slow decline in phase III clinical trial

by Alzheimer's Research UKCredit: Pixabay/CC0 Public DomainThe pharmaceutical company Roche has announced that two phase III trials of the potential Alzheimer's drug gantenerumab did not
New figures show dementia is leading cause of death in England and Wales

New figures show dementia is leading cause of death in England and Wales

by Alzheimer's Research UKNew figures released by the Office of National Statistics show that for the first time, Alzheimer's disease and other dementias are the leading cause of death fo

New figures show dementia is leading cause of death in England and Wales

by Alzheimer's Research UKNew figures released by the Office of National Statistics show that for the first time, Alzheimer's disease and other dementias are the leading cause of death fo
Those with stroke risk factors may be more likely to have severe strokes

Those with stroke risk factors may be more likely to have severe strokes

byAmerican Academy of NeurologyCredit: Pixabay/CC0 Public DomainPeople with conditions or habits such as high blood pressure, an irregular heartbeat called atrial fibrillation, or smoking, not o

Those with stroke risk factors may be more likely to have severe strokes

byAmerican Academy of NeurologyCredit: Pixabay/CC0 Public DomainPeople with conditions or habits such as high blood pressure, an irregular heartbeat called atrial fibrillation, or smoking, not o
Estrogen drug may not benefit women with Alzheimer's dementia

Estrogen drug may not benefit women with Alzheimer's dementia

by American Academy of NeurologyDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.An estrogen-like drug, raloxifene, has no demonstrated benefit on me

Estrogen drug may not benefit women with Alzheimer's dementia

by American Academy of NeurologyDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.An estrogen-like drug, raloxifene, has no demonstrated benefit on me
Neck scan could predict risk of developing cognitive decline

Neck scan could predict risk of developing cognitive decline

by Rowan Walker,University College LondonRed blood cells. Credit: PixabayA five-minute scan of blood vessels in the neck during mid-life could predict cognitive decline ten years before symptoms

Neck scan could predict risk of developing cognitive decline

by Rowan Walker,University College LondonRed blood cells. Credit: PixabayA five-minute scan of blood vessels in the neck during mid-life could predict cognitive decline ten years before symptoms